Begoña Rivas
Hospital Universitario La Paz
14 Papers
27 Citations
Begoña Rivas is an academic researcher from Hospital Universitario La Paz. The author has contributed to research in topics: Medicine & Kidney disease. The author has an hindex of 5, co-authored 10 publications.
Chat about Author
Papers
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Gema Fernández-Juárez,Jorge Rojas-Rivera,Anne-Els van de Logt,Joana Justino,Angel Sevillano,Fernando Caravaca-Fontán,Ana Ávila,Cristina Rabasco,Virginia Cabello,Alfonso Varela,Montserrat Díez,Guillermo Martín-Reyes,Marian Goicoechea Diezhandino,Luis F. Quintana,Irene Agraz,Juan Ramón Gómez-Martino,Mercedes Cao,Antolina Rodríguez-Moreno,Begoña Rivas,Cristina Galeano,Jose Bonet,Ana María Romera,Amir Shabaka,Emmanuelle Plaisier,Emmanuelle Plaisier,Mario Espinosa,Jesús Egido,Alfonso Segarra,Gérard Lambeau,Pierre Ronco,Pierre Ronco,Jack F.M. Wetzels,Manuel Praga,Hernando Trujillo,Eduardo Gutiérrez,Gema Fernandez Juarez,Alberto Ortiz,Marian Goicoechea,Ursula Verdalles,Alfons Segarra,Lara Perea,Ildefonso Valera,Mónica Martín,Miguel Angel Pérez Valdivia,Miquel Blasco,Andrés López Muñiz,Tamara Malek,Montserrat Diaz,Iara daSilva,Jordi Bonet,Maruja Navarro,Ana Huerta,Ezequiel Rodríguez-Paternina,Ana Vigil,Roberto Alcázar,Vicente Paraiso,Vicente Barrio,Julia M. Hofstra +57 more
TL;DR: Treatment with corticosteroid-cyclophosphamide induced remission in a significantly greater number of patients with primary membranous nephropathy than tacrolimus-rituximab, and serious adverse events were similar in both groups.
171
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
Cristina Rabasco,Teresa Cavero,Elena Román,Jorge Rojas-Rivera,Teresa Olea,Mario Espinosa,Virginia Cabello,Gema Fernández-Juárez,F. González,Ana Ávila,José Baltar,Montserrat Diaz,Raquel Alegre,Sandra Elías,Monserrat Antón,Miguel Angel Frutos,Alfonso Pobes,Miguel Blasco,Francisco Martín,Carmen Bernis,Manuel Macías,Sergio Barroso,Alberto de Lorenzo,Gema Ariceta,Manuel López-Mendoza,Begoña Rivas,Katia López-Revuelta,José María Campistol,Santiago Mendizábal,Santiago Rodríguez de Córdoba,Manuel Praga +30 more
TL;DR: Renal survival and the number of patients achieving clinical remission were significantly higher in patients treating with corticosteroids plus mycophenolate mofetil as compared with patients treated with other immunosuppressive regimens and untreated patients, respectively.
150
Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.
María O. López-Oliva,Virginia Martínez,Agueda Buitrago,Carlos Jiménez,Begoña Rivas,Fernando Escuin,Maria J. Santana,Rafael Selgas,Teresa Bellón +8 more
TL;DR: Assessment of IE-1-specific CD8 T-cell frequencies pretransplant may be a useful tool for identifying seropositive SOT patients at risk of developing CMV infection posttransplant.
43
Complicaciones asociadas a la biopsia de injertos renales en pacientes trasplantados
Claudia Tapia-Canelas,Rosa Zometa,María O. López-Oliva,Carlos Jiménez,Begoña Rivas,Fernando Escuin,Laura Yébenes,Rafael Selgas +7 more
TL;DR: La tasa de compli - caciones relacionadas with the biopsia del injerto renal observada en nuestro centro es similar a las descritas sobre rinones nativos.
21
Pretransplant peritoneal dialysis relative to hemodialysis improves long-term survival of kidney transplant patients: a single-center observational study
María O. López-Oliva,Begoña Rivas,Elia Pérez-Fernández,Marta Ossorio,Silvia Ros,Carlos Chica,Ana Aguilar,Maria-Auxiliadora Bajo,Fernando Escuin,Luis Hidalgo,Rafael Selgas,Carlos Jiménez +11 more
TL;DR: Pretransplantation dialysis modality is associated with long-term patient survival, with outcomes favoring peritoneal dialysis over hemodialysis, however, the pretransplant dialysismodality does not influence long- term graft loss risk.
20